The number of opioid prescriptions filled by Medicare and Medicaid patients falls dramatically once states legalize marijuana, two major new studies show.
The cost to first responders of the overdose-reversing drug naloxone has increased dramatically in recent years, and some U.S. Senators are now demanding that pharmaceutical companies explain their price hikes.
President Trump’s recently announced opioid plan is drawing questions because it proposes treating all addicted federal inmates with Vivitrol – a non-generic drug manufactured by a single company – rather than allowing clinicians to select the form of medication-assisted treatment they think will work best in each particular case.
A bill making its way through the California legislature is designed to stop unscrupulous rehab centers and patient brokers from improperly signing patients up for private insurance and then bilking the insurance companies for inflated costs.
A bill that has a good chance of becoming law this year would allow doctors and hospitals to access a patient’s medical records involving alcohol and drug abuse without the patient’s consent.
The Justice Department has announced an investigation into whether states are violating the Americans With Disabilities Act if they refuse to provide methadone, buprenorphine, or other anti-addiction drugs to people in state prisons.
As the U.S. Drug Enforcement Administration demands a sharp cutback in opioid production, many hospitals are reporting a “potentially life-threatening” shortage of standard painkillers, sometimes leading to postponement of surgeries as well as impromptu substitutions and a much greater likelihood of medical errors.
Marijuana and tobacco laced with insecticides such as Raid – known on the street as “Katie” or KD – are apparently highly addictive and leading to overdoses, according to first responders ... although the manufacturer of Raid denies this.
The Missouri Senate has approved a plan to have the state’s Medicaid program pay for chiropractic treatment, in part as a way to keep people from taking opioid painkillers and becoming addicted.
More than 17 percent of American adults binge-drink at least once a week, consuming an average of seven drinks when they do, according to new research in the American Journal of Preventive Medicine. And half of all binge-drinks are consumed by people over age 35.
Although the number of benzodiazepines prescribed for patients over age 65 declined slightly from 2010 to 2016, the drugs are still being given to the elderly far more often than they should be, creating a significant and unnecessary risk of addiction, a new study finds.
The first longitudinal study to examine whether popular secular alternatives are as effective as Twelve-Step programs has reported its results, and they’re … complicated.
Google has temporarily banned all advertising by addiction rehab centers around the world while it figures out how to combat the problem of shady rehab operators gaming its AdWords system to direct people to substandard treatment facilities.
Opioid manufacturers paid large amounts of money to doctors who wrote a lot of opioid prescriptions in 2014 and 2015, according to a study by Harvard researchers. Hundreds of doctors received six-figure payments, and thousands more were paid at least $25,000.